These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36243667)

  • 21. Varicella-zoster virus seroprevalence in healthcare workers in Kuala Lumpur, Malaysia.
    Sam IC; Tariman H; Chan YF; Bador MK; Yusof MY; Hassan H
    Med J Malaysia; 2008 Dec; 63(5):429-30. PubMed ID: 19803311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case report: Hospital-acquired chickenpox in a healthcare setting.
    Utpat S; Utpat N; Nookala V; Podakula L; Utpat K
    Epidemiol Infect; 2023 Dec; 152():e3. PubMed ID: 38112097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Varicella zoster virus in health care workers in northern Israel: seroprevalence and predictive value of history of varicella infection.
    Chazan B; Colodner R; Teitler N; Chen Y; Raz R
    Am J Infect Control; 2008 Aug; 36(6):436-8. PubMed ID: 18675150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroprevalence of antibodies against varicella zoster virus and rubella virus among newly recruited expatriate healthcare workers: a cross-sectional study.
    Shady I
    BMJ Open; 2018 Mar; 8(3):e019339. PubMed ID: 29567844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seroprevalence of measles, mumps, rubella, and varicella zoster virus antibodies among healthcare students: analysis of vaccine efficacy and cost-effectiveness.
    Ödemiş Í; Köse Ş; Akbulut Í; Albayrak H
    Rev Esp Quimioter; 2019 Dec; 32(6):525-531. PubMed ID: 31642641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroepidemiology of varicella-zoster virus antibodies among health-care workers and day-care-centre workers.
    Lerman Y; Chodick G; Tepper S; Livni G; Ashkenazi S
    Epidemiol Infect; 2004 Dec; 132(6):1135-8. PubMed ID: 15635972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seroprevalence and molecular characteristics of varicella-zoster virus infection in Chinese children.
    Luan L; Shen X; Qiu J; Jing Y; Zhang J; Wang J; Zhang J; Dong C
    BMC Infect Dis; 2019 Jul; 19(1):643. PubMed ID: 31324226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serologic analysis of the IgG antibody response in children with varicella zoster virus wild-type infection and vaccination.
    Jenke AC; Klein S; Baiker A; Wirth S; Sander M; Noelting C; Boecher O; Vizoso-Pinto MG
    Pediatr Infect Dis J; 2012 Nov; 31(11):1148-52. PubMed ID: 22863912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Varicella immunity in vaccinated healthcare workers.
    Behrman A; Lopez AS; Chaves SS; Watson BM; Schmid DS
    J Clin Virol; 2013 Jun; 57(2):109-14. PubMed ID: 23434396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX™) in healthy infants, children, and adolescents.
    Paradis EM; Tikhonov O; Cao X; Kharit SM; Fokin A; Platt HL; Wittke F; Jotterand V
    Hum Vaccin Immunother; 2021 Nov; 17(11):4183-4189. PubMed ID: 34702124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Varicella screening and vaccination for healthcare workers at KK Women's and Children's Hospital.
    Chong CY; Lim SH; Ng WY; Tee N; Lin RV
    Ann Acad Med Singap; 2004 Mar; 33(2):243-7. PubMed ID: 15098642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroprevalence of Varicella Zoster Virus in the Eastern Province of Saudi Arabia in Post-vaccination Era.
    Al Dossary R
    Med Arch; 2023; 77(5):358-362. PubMed ID: 38299088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX™) in healthy adults.
    Paradis EM; Tikhonov O; Cao X; Kharit SM; Fokin A; Platt HL; Banniettis N
    Hum Vaccin Immunother; 2021 Nov; 17(11):4177-4182. PubMed ID: 34473594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Humoral and cellular response after varicella vaccination in VZV IgG seronegative kidney transplant candidates.
    Kho MM; Zuijderwijk JM; van der Eijk AA; de Kuiper R; Boer-Verschragen MJ; Weimar W; van Besouw NM
    Vaccine; 2017 Jan; 35(1):71-76. PubMed ID: 27899225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid, sensitive, and specific lateral-flow immunochromatographic point-of-care device for detection of varicella-zoster virus immunoglobulin G antibodies in fingerstick blood.
    Vafai N; Self K; Sheffield B; Hojvat S; Kusi-Appiah A; Vaughan P; Cowan E; Vafai A
    J Immunol Methods; 2023 Mar; 514():113429. PubMed ID: 36690067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
    Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
    Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans.
    Sullivan NL; Reuter-Monslow MA; Sei J; Durr E; Davis CW; Chang C; McCausland M; Wieland A; Krah D; Rouphael N; Mehta AK; Mulligan MJ; Pulendran B; Ahmed R; Vora KA
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroprevalence of Varicella-Zoster Virus and Measles among Healthcare Workers in a Tertiary Medical Center in Korea.
    Yun JH; Lee E; Choi JH; Ki HK; Park J
    Vaccines (Basel); 2022 Nov; 10(11):. PubMed ID: 36423051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occupational risk of infection by varicella zoster virus in Belgian healthcare workers: a seroprevalence study.
    Vandersmissen G; Moens G; Vranckx R; de Schryver A; Jacques P
    Occup Environ Med; 2000 Sep; 57(9):621-6. PubMed ID: 10935943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age.
    Parment PA; Svahn A; Rudén U; Bråkenhielm G; Storsaeter J; Akesson L; Linde A
    Scand J Infect Dis; 2003; 35(10):736-42. PubMed ID: 14606613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.